Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
Coombes RC, Howell S, Lord SR, Kenny L, Mansi J, Mitri Z, Palmieri C, Chap LI, Richards P, Gradishar W, Sardesai S, Melear J, O'Shaughnessy J, Ward P, Chalasani P, Arkenau T, Baird RD, Jeselsohn R, Ali S, Clack G, Bahl A, McIntosh S, Krebs MG.
Coombes RC, et al.
Nat Commun. 2023 Jul 24;14(1):4444. doi: 10.1038/s41467-023-40061-y.
Nat Commun. 2023.
PMID: 37488191
Free PMC article.
Clinical Trial.